Engineered Bacteria for Enhanced Radiotherapy against Breast Carcinoma

ACS Nano. 2022 Jan 25;16(1):801-812. doi: 10.1021/acsnano.1c08350. Epub 2022 Jan 14.

Abstract

Radiotherapy is widely applied for multiple malignant tumors ablation in the clinic. However, redundant doses of X-rays might destroy normal tissue in the periphery of tumor sites. Here, we developed an integrated nanosystem (Bac@BNP) composed of engineered bacteria (Bac) and Bi2S3 nanoparticles (BNPs) for sensitizing radiotherapy. Bac could target and colonize in tumor sites alternatively, which overexpressed cytolysin A (ClyA) protein to regulate the cell cycle from a radioresistant phase to a radiosensitive phase. Simultaneously, peptide-modified BNPs, as a radiosensitizer with a high-Z element, was released from the surface of Bac owing to the matrix metalloproteinase-2 (MMP-2) response in the tumor microenvironment. Under X-ray irradiation, BNPs could enhance the radiotherapy sensitivity by triggering the intracellular generation of reactive oxygen species (ROS), coupled with DNA damage. In this constructed nanosystem, the combination of Bac@BNP and X-ray irradiation led to significant suppression of breast carcinoma in murine models with reduced side effects.

Keywords: bacterial; cell cycle; nanoparticle; radiosentization; tumor therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacteria / metabolism
  • Breast Neoplasms* / radiotherapy
  • Cell Line, Tumor
  • Matrix Metalloproteinase 2
  • Mice
  • Nanoparticles*
  • Radiation-Sensitizing Agents*
  • Reactive Oxygen Species / metabolism
  • Tumor Microenvironment

Substances

  • Matrix Metalloproteinase 2
  • Radiation-Sensitizing Agents
  • Reactive Oxygen Species